The partners at the centre of Blis patent dispute named

The partners at the centre of Blis patent dispute named
The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015. (Image: NZME)
Denise McNabb
Two executives from Blis Technologies’ long-time European partner, Bluestone Pharma, are named on a patent application as inventors of two fermentation processes Blis claims as its own technology.The executives are Michael Faber, Swiss-registered Bluestone Pharma’s managing partner, and Karsten Brandt, its chief scientific officer. The Swiss-registered Spanish company signed an exclusive deal with Blis in 2015 to distribute its healthcare products in Europe. At the time, Blis said the relationship with Bluestone Pharma (BP) hel...

More Markets

Govt support needed to make sustainable aviation fuel
Markets

Govt support needed to make sustainable aviation fuel

Other countries may hesitate to export sustainable aviation fuel to NZ.

Too few NZ ports earning 'appropriate returns'
Infrastructure

Too few NZ ports earning 'appropriate returns'

Port returns over the past decade 'disappointing and alarming'. 

Fonterra urges Canada to 'play by the rules'
Primary Sector

Fonterra urges Canada to 'play by the rules'

NZ, US and Australia believe Canada is undermining legitimate export interests.